Healome Therapeutics to accelerate development for ocular disease
Studies have demonstrated that Healome’s formulations have anti-fibrotic activity and are augmented when combined with other therapeutics
Read More
Tag: Healome
- NHS reduces long waits for cancer care and achieves faster ambulance responses
- MHRA’s AI Airlock to address challenges for regulating AI medical devices
- Oregon and Lantern collaborate to develop drug candidate for various cancer indications
- OneChain’s CAR T trial treats its first cortical T-cell ALL patient
- Johns Hopkins scientists depict molecular pathway to track replication in cancer cells
